glp-1 drugs history Continued growth for receptor agonists and SGLT-2 inhibitors in 2017 Oral Small-Molecule GLP-1 Receptor Agonists:
Description
& LeRoith, D
13 Owing to the increasing trends of obesity and type 2 diabetes, the number of patients with clinical indications for treatment with GLP-1 RA will continue to increase in the upcoming years
Of those that dont currently cover the drugs for weight loss, 54% say theyre unlikely to do so soon, while just 6% are likely to add coverage in the near term
10.1038/s41598-023-48267-2
To request prior authorization for a GLP-1 medication, you and your healthcare provider must work together to submit a formal request to your insurance company
B.ZekavatS
